Study of Intraperitoneal chemotherapy in gastric cancer:
Not Applicable
- Conditions
- Health Condition 1: null- Gastric Cancer
- Registration Number
- CTRI/2018/01/011056
- Lead Sponsor
- AIIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients 18-75 years old, with a diagnosis of adenocarcinoma of the stomach with T stage equal to or higher than T2 (including patients who received neoadjuvant therapy) as assessed by CECT and/or intraoperatively
Exclusion Criteria
1.Unwilling to consent for the study.
2.ECOG status >2
3.Developing hemodynamic instability during surgical procedures.
4.Bone marrow suppression.
5. R2 resection .
6.Patients found to have widespread metastasis (not amenable to cytoreduction) or an unresectable lesion, evidence of extensive para-aortic/retropancreatic lymph node metastasis on imaging.
7.Active systemic infection or any associated medical problem that has an unacceptable risk for a major surgical procedure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method